Document Detail

Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease.
MedLine Citation:
PMID:  11924899     Owner:  NLM     Status:  MEDLINE    
Twenty seven patients with mild AD were enrolled in a prospective open label controlled study of rivastigmine. Assessments included a range of neuropsychiatric and behavioural measures and rCBF using HMPAO SPECTat baseline, three and six months. Significant enhancement of frontal, parietal and temporal brain blood flow with related psychometric improvement was observed in twelve of the treated patients. A pattern of reduced rCBF and cognitive performance was observed in four unresponsive and eleven untreated patients. The results suggest that alterations in the clinical and cognitive status of patients receiving a cholinesterase inhibitor are paralleled by changes in rCBF. Longitudinal assessment with repeated imaging offers a method of better understanding the effects of cholinesterase inhibition on the AD brain.
Annalena Venneri; Michael F Shanks; Roger T Staff; Simon J Pestell; Katrina E Forbes; Howard G Gemmell; Alison D Murray
Related Documents :
2772979 - Evaluation of cerebral blood flow data in stroke patients using a mapping system.
495039 - "hyperfrontal" distribution of the cerebral grey matter flow in resting wakefulness; on...
7847159 - Change in regional cerebral blood flow following glycerol administration predicts. clin...
19892319 - Catechol-o-methyltransferase valine(158)methionine genotype and resting regional cerebr...
9345479 - A new technique for quantitative imaging of cerebrovascular reserve capacity using a do...
22689949 - Perivascular-resident macrophage-like melanocytes in the inner ear are essential for th...
19032299 - The effect of pneumoperitoneum and trendelenburg position on acute cerebral blood flow-...
10095859 - Effects of trimetaphan-induced deliberate hypotension on human cochlear blood flow.
11696249 - The dynamics of venous return and response to hypervolemia in the toad, bufo marinus (l.).
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neuroreport     Volume:  13     ISSN:  0959-4965     ISO Abbreviation:  Neuroreport     Publication Date:  2002 Jan 
Date Detail:
Created Date:  2002-04-01     Completed Date:  2002-07-18     Revised Date:  2009-02-11    
Medline Journal Info:
Nlm Unique ID:  9100935     Medline TA:  Neuroreport     Country:  England    
Other Details:
Languages:  eng     Pagination:  83-7     Citation Subset:  IM    
Department of Psychology, University of Aberdeen, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alzheimer Disease / drug therapy*,  physiopathology,  psychology
Carbamates / therapeutic use*
Cerebrovascular Circulation / drug effects*
Cholinesterase Inhibitors / therapeutic use*
Cluster Analysis
Cognition / drug effects*
Longitudinal Studies
Neuropsychological Tests
Prospective Studies
Radiopharmaceuticals / diagnostic use
Technetium Tc 99m Exametazime / diagnostic use
Time Factors
Tomography, Emission-Computed, Single-Photon
Reg. No./Substance:
0/Carbamates; 0/Cholinesterase Inhibitors; 0/Phenylcarbamates; 0/Radiopharmaceuticals; 100504-35-6/Technetium Tc 99m Exametazime; 123441-03-2/rivastigmine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral ve...
Next Document:  Effect of melatonin on rat spinal cord nociceptive transmission.